Equities

Aurobindo Pharma Ltd

AUROPHARMA:NSI

Aurobindo Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,111.10
  • Today's Change25.80 / 2.38%
  • Shares traded1.70m
  • 1 Year change+96.55%
  • Beta0.8946
Data delayed at least 15 minutes, as of Apr 16 2024 11:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • AUROPHARMA:NSI trading volume exceeds daily average by +15.59%
  • AUROPHARMA:NSI price moved over -1.02% to 1,097.30
  • AUROPHARMA:NSI price rises above 15-day moving average to 1,101.05 at 12:52 BST
  • AUROPHARMA:NSI price falls below 15-day moving average to 1,083.00 at 12:50 BST

Key statistics

On Tuesday, Aurobindo Pharma Ltd (AUROPHARMA:NSI) closed at 1,111.10, -5.61% below its 52-week high of 1,177.10, set on Jan 30, 2024.
52-week range
Today
556.10Apr 17 20231,177.10Jan 30 2024
Open1,075.00
High1,117.20
Low1,069.30
Bid--
Offer1,111.10
Previous close1,085.30
Average volume1.81m
Shares outstanding585.94m
Free float280.87m
P/E (TTM)22.97
Market cap635.92bn INR
EPS (TTM)47.25
INR
Annual div (ADY)4.50
INR
Annual div yield (ADY)0.41%
Div ex-dateFeb 20 2024
Div pay-dateMar 04 2024
Data delayed at least 15 minutes, as of Apr 16 2024 11:15 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.